Sign inJoin waitlistJoin the waitlist

David Standaert

Professor and Chair · University of Alabama Hospital

Credentials: · · · · ·

History

University of Alabama Hospital
Present
Department of Neurology · University of Alabama Hospital
Present
Neurology Department · University of California (San Diego) Medical Center
Present

Neurology
1988–1992
Washington University School of Medicine
1984–1988

Research

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Review · Movement Disorders · 2017 · 613 citations
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
Science · 2002 · 560 citations
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
The Lancet Neurology · 2014 · 527 citations

AY
Anne Young
38 papers
Irene Litvan
21 papers
Talene Yacoubian
20 papers
Amy Amara
18 papers · 1 as a fellow
Claudia Testa
15 papers · 4 as a resident
Marissa Dean
13 papers
Deborah Hall
12 papers
Hubert Fernandez
11 papers
Alberto Espay
10 papers
Benzi Kluger
10 papers
DR
David Riley
10 papers
David Shprecher
10 papers

Grants

Innate and Adaptive Immunity in Parkinson Disease
National Institute of Neurological Disorders and Stroke · P50
Contact PI · $9.9M · University of Alabama at Birmingham
2018–2025
UAB Research Education Program for Residents and Fellows in Neuroscience
National Institute of Neurological Disorders and Stroke · R25
Contact PI · $1.1M · University of Alabama at Birmingham
2012–2023
UAB Training Program in Neurodegeneration
National Institute of Neurological Disorders and Stroke · T32
Contact PI · $688.3K · University of Alabama at Birmingham
2017–2022
Molecular Etiology of Early Onset Dystonia
National Institute of Neurological Disorders and Stroke · P01
Project lead · $1.4M · Massachusetts General Hospital
2021

Clinical trials

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214
Principal investigator · Unknown · Phase 1
Serina Therapeutics
2016–2023
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
Study director · Recruiting · Early phase 1
University of Alabama at Birmingham
2024–2028
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Sub-investigator · Recruiting
Michael J. Fox Foundation for Parkinson's Research
2020–2027
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Sub-investigator · Recruiting
Michael J. Fox Foundation for Parkinson's Research
2020–2033